RW epcor R/R LBCL outcomes (CUBIC Consortium):
- 157 pts, 55% prior CAR, 46% trial ineligible
- ORR 50%, CR 32%
- mPFS 3.5 mo, mOS OS 7.6 mo
- 1-year PFS 29%, 1-year OS 38%
- ⬇️survival: poor PS,⬆️LDH, refractory, trial ineligible
1/ #lymsm
pubmed.ncbi.nlm.nih.gov/42263668/
Ajay Major, MD, MBA
